5-Amino-1MQ: NNMT research and evidence limits
5-Amino-1MQ belongs in a small-molecule research category, despite appearing in many peptide catalogs. Interest centers on inhibiting nicotinamide N-methyltransferase, or NNMT. The selected evidence supports studying that target in metabolism and muscle repair; it does not establish a consumer weight-loss or anti-aging treatment.
Identity and formulation
NNMT is an enzyme, not a peptide hormone. Genetic reduction of the enzyme, exposure to an experimental inhibitor, and administration of a specific commercial chemical are three different interventions.
The 2017 inhibitor paper describes methylquinolinium compounds. Its abstract does not identify every lead by the retail name 5-Amino-1MQ, so matching a particular tested structure requires the full methods and chemical characterization.
What the studies show
The key papers reviewed here involve cells and mice. They are useful for asking whether NNMT biology affects fat metabolism or regeneration. They do not provide controlled human body-composition outcomes or a validated human safety margin for a retail 5-Amino-1MQ preparation.
| Study and design | Finding | What it does not establish |
|---|---|---|
| Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.
Genetic NNMT knockdown and mouse metabolic experiments Reading scope: PubMed abstract and bibliographic record; not full-text review |
Reducing NNMT expression protected against diet-induced obesity and altered metabolic pathways. | Target validation by gene knockdown is not a trial of 5-Amino-1MQ. |
| Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice.
Cultured adipocytes and diet-induced obese mice Reading scope: PubMed abstract and bibliographic record; not full-text review |
Selected membrane-permeable NNMT inhibitors affected adipocyte metabolism and reduced obesity-related measures in mice. | The abstract concerns an inhibitor series; species and exact chemical identity limit transfer to a named human product. |
| Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle.
Cell experiments and injured muscle in aged mice Reading scope: PubMed abstract and bibliographic record; not full-text review |
An experimental NNMT inhibitor was associated with improved muscle regeneration and functional recovery in the studied model. | An acute injury model in aged mice does not demonstrate general human muscle growth or longevity. |
For the differences between a mechanism, a biomarker and a clinical outcome, see the evidence-reading guide.
How to interpret the findings
An enzyme can be a plausible drug target without every inhibitor being equally selective, bioavailable or safe. The crucial next evidence would identify the tested molecule, exposure and off-target activity before moving to controlled human outcomes.
Weight change, fat mass and muscle repair are distinct endpoints. A positive result in one does not justify a combined promise of effortless fat loss, greater strength and slower aging.
Safety context
The studies summarized here do not establish long-term human tolerability. A lack of reported human adverse events in these animal experiments cannot be interpreted as a clean human safety record.
Study exposure and units
Read experimental concentrations and animal exposures as features of those experiments. They cannot establish a starting dose, cycling schedule or oral-to-injection conversion for people.
Any exposure summary should identify which NNMT inhibitor was actually tested; a paper about an unspecified lead cannot populate a universal 5-Amino-1MQ dosage box.
Match any reported amount or concentration to the exact material, route, population and duration in the original experiment. Read the guide to mass, volume and concentration for the meaning of common units. A calculation cannot establish an appropriate treatment or validate an untested formulation.
Product identity and report checks
Require an unambiguous chemical name, structure or validated identifier and the salt/counterion, rather than the abbreviation alone.
Match identity and quantity assays to that chemical form. A peptide-style purity badge does not demonstrate NNMT inhibition, clinical effectiveness or suitability for human use.
Keep the clinical evidence and the supplier evidence separate. Use the report-verification steps to check the issuer and the batch questions to connect a tested sample with the product offered. Compare prices using the delivered-cost method rather than an isolated discount or purity percentage.
Peptide Serum operates a store as well as this research library. The supplier directory contains imported seller information; a listing is not laboratory certification. Read how this library is prepared and evaluate the documentation for the exact lot offered. A seller rating does not establish clinical safety or effectiveness.
Common questions
Does inhibiting NNMT prove 5-Amino-1MQ works for weight loss in people?
No. The target studies make a research case, but a human claim requires a chemically matched intervention, a comparator and measured outcomes in people. A mouse result is not an expected percentage of human fat loss.
Is it interchangeable with a peptide sold for weight management?
No. Chemical class and mechanism differ. A shared sales category does not make their evidence, exposure or risks interchangeable.
Sources
- Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. (PubMed abstract and bibliographic record; not full-text review)
- Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. (PubMed abstract and bibliographic record; not full-text review)
- Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. (PubMed abstract and bibliographic record; not full-text review)
- PubChem: 5-amino-1-methylquinolinium (Official chemical record: structure, name and identifiers)